Inventor · disambiguated record
Jeffrey Aube
Also filed as: AUBE JEFFREY · AUBÉ JEFFREY
24 granted patents·9 pending applications·45 citations·filing 2008–2023
93Inventor score
Top patents by PatentIndex Score
33 records- 0187US9642835B2Modulators of GTPase and use in relevant treatmentSTC UNM·Filed 2013·Granted May 9, 2017·4 cites·35 claims
- 0286US10118896B2Antagonists of the kappa opioid receptorUNIV KANSAS·Filed 2015·Granted Nov 6, 2018·4 cites·18 claims
- 0384US9056111B1Selective efflux inhibitors and related pharmaceutical compositions and methods of treatmentSTC UNM·Filed 2012·Granted Jun 16, 2015·6 cites·16 claims
- 0483US8765803B1Rab7 GTPase inhibitors and related methods of treatmentWANDINGER-NESS ANGELA·Filed 2012·Granted Jul 1, 2014·6 cites·3 claims
- 0582US9540375B2Kappa opioid receptor effectors and uses thereofUNIV KANSAS·Filed 2016·Granted Jan 10, 2017·4 cites·2 claims
- 0676US8598339B2Withanolide isolated from Physalis longifolia and analogs and methods of use thereofTIMMERMANN BARBARA N·Filed 2012·Granted Dec 3, 2013·11 cites·3 claims
- 0774US8362072B2BRCA1-based breast or ovarian cancer treatment agents and methods of useUNIV KANSAS·Filed 2012·Granted Jan 29, 2013·1 cites·9 claims
- 0873US9376452B2Rab7 GTPase inhibitors and related methods of treatmentSTC UNM·Filed 2014·Granted Jun 28, 2016·1 cites·12 claims
- 0973US8865708B2Methods and compositions for inhibition of the transitional endoplasmic reticulum ATPaseDESHAIES RAYMOND J·Filed 2011·Granted Oct 21, 2014·2 cites·18 claims
- 1071US12145922B2Selective D3 dopamine receptor agonists and methods of their useUS HEALTH·Filed 2023·Granted Nov 19, 2024·0 cites·21 claims
- 1171US8193235B2Compositions and methods for establishing and maintaining stem cells in an undifferentiated statePAUL SOUMEN·Filed 2010·Granted Jun 5, 2012·4 cites·1 claims
- 1270US9345703B2Kappa opioid receptor effectors and uses thereofAUBE JEFFREY·Filed 2012·Granted May 24, 2016·1 cites·5 claims
- 1366US9580393B26-substituted quinazolinone inhibitorsUNIV KANSAS·Filed 2013·Granted Feb 28, 2017·1 cites·20 claims
- 1465US2009170842A1Brca1-based breast or ovarian cancer prevention agents and methods of useUNIV KANSAS·Filed 2008·Application pending·0 cites
- 1565US2015197526A1Selective efflux inhibitors and related pharmaceutical compositions and methods of treatmentSTC UNM·Filed 2014·Application pending·0 cites
- 1663US8735391B2Synthesis of functionalized octahydro-isoquinolin-1-one-8-carboxamides, octahydro-isoquinolin-1-one-8-carboxylic esters and analogs, and therapeutic methodsAUBE JEFFREY·Filed 2009·Granted May 27, 2014·0 cites·2 claims
- 1762US9732067B2Compounds and methods for activating the apoptotic arm of the unfolded protein responseUNIV KANSAS·Filed 2013·Granted Aug 15, 2017·0 cites·7 claims
- 1861US10787439B2Compounds and methods for activating the apoptotic arm of the unfolded protein responseUNIV KANSAS·Filed 2017·Granted Sep 29, 2020·0 cites·1 claims
- 1960US10829453B2Antagonists of the kappa opioid receptorUNIV KANSAS·Filed 2018·Granted Nov 10, 2020·0 cites·11 claims
- 2057US2024254107A1Rna-targeting ligands, compositions thereof, and methods of making and using the sameUNIV NORTH CAROLINA CHAPEL HILL·Filed 2022·Application pending·0 cites
- 2156US10532999B26-substituted quinazolinone inhibitorsUNIV KANSAS·Filed 2018·Granted Jan 14, 2020·0 cites·20 claims
- 2255US11634404B2Selective D3 dopamine receptor agonists and methods of their useUS HEALTH·Filed 2017·Granted Apr 25, 2023·0 cites·16 claims
- 2352US2016244457A1Selective efflux inhibitors and related pharmaceutical compositions and methods of treatmentUNIV KANSAS·Filed 2016·Application pending·0 cites
- 2451US10087168B26-substituted quinazolinone inhibitorsUNIV KANSAS·Filed 2017·Granted Oct 2, 2018·0 cites·16 claims
- 2551US2014243333A1Synthesis of functionalized octahydro-isoquinolin-1-one-8-carboxylic esters and analogs, and therapeutic methodsUNIV KANSAS·Filed 2014·Application pending·0 cites
- 2648US2022289688A1Rna-targeting ligands, compositions thereof, and methods of making and using the sameUNIV NORTH CAROLINA CHAPEL HILL·Filed 2020·Application pending·0 cites
- 2747US10059722B2Cephalosporin derivatives and methods of useUNIV KANSAS·Filed 2013·Granted Aug 28, 2018·0 cites·6 claims
- 2843US2009318454A1Novel antioxidants and methods of treatmentWEINER CARL P·Filed 2009·Application pending·0 cites
- 2942US9464064B2HCV helicase inhibitors and methods of use thereofAUBE JEFFREY·Filed 2012·Granted Oct 11, 2016·0 cites·4 claims
- 3041US2021040074A1Positive allosteric modulators of dopamine 1 receptor and method of use thereofSIBLEY DAVID R·Filed 2019·Application pending·0 cites
- 3139US9499496B2Inhibitors of respiratory syncytial virusUNIV KANSAS·Filed 2013·Granted Nov 22, 2016·0 cites·43 claims
- 3238US2012270313A1Compositions and Methods for Establishing and Maintaining Stem Cells in an Undiffferentiated StatePAUL SOUMEN·Filed 2012·Application pending·0 cites
- 3333US9611270B2Inhibitors of CYP17A1UNIV KANSAS·Filed 2015·Granted Apr 4, 2017·0 cites·22 claims
Join the waitlist — get patent alerts
Get an alert when Jeffrey Aube files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →